Study to Asses Efficacy of Intralymphatic Immunotherapy

NCT01166269 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rigshospitalet, Denmark

Collaborators